We acted as an advisor for Kaiku Health (previously NetMedi Oy) and its shareholders when NetMedi organised an investment round to expand its international operations and continue the development of its digital therapeutics pipeline. As a result, Kaiku Health closed a €4.4 million funding round. The investment was led by Debiopharm Innovation Fund SA and Tesi, with the participation of existing investors.